0551 (0551) Fair Value & Analysis

Consumer Cyclical · Market cap HK$19.7B

0 0551 0551 · HK

PriceHK$12.25

Fair ValueHK$4.04

Upside-67.0%

Quality58/100

Evidence: Medium Range HK$2.87 – HK$5.05

Fair value as of: Jul 2, 2026

From 25 valuation models · updated today

Share price −11.0% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$9.98 – HK$17.82 · fair‑value band HK$2.87 – HK$5.05 · the HK$12.25 price screens above the HK$4.04 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0551 (0551) currently trades at HK$12.25, while our model-based Fair Value estimate is HK$4.04 — implying the stock looks roughly 67.0% overvalued today. We read business quality at 58/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 0551 generated revenue of HK$8.0B at a net margin of 4.3%. Revenue declined 2.2% year over year. It earns a return on equity of 7.9%. Net debt stands at HK$341M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$8.0B

Revenue growth (YoY) -2.2%

Net margin 4.3%

Return on equity 7.9%

Free cash flow HK$313M FY2025

P/E ratio 6.6

More key figures

Operating margin 2.4%

EPS (TTM) HK$0.1266

EPS growth (YoY) +68.5%

Net debt HK$341M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0551 reported revenue of HK$8.0B in FY2025 versus HK$8.5B in FY2021, a compound −1.5%/yr. Reported net income was HK$381M in FY2025, compounding +34.9%/yr from FY2021.

Revenue −1.5%/yr

FY21 HK$8.5B

FY22 HK$9.0B

FY23 HK$7.9B

FY24 HK$8.2B

FY25 HK$8.0B

Net income +34.9%/yr

FY21 HK$115M

FY22 HK$296M

FY23 HK$275M

FY24 HK$392M

FY25 HK$381M

Is 0551 fairly valued? → Check now

Similar stocks

6 more Footwear & Accessories stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
NIKE, Inc NKE	€38.41	€31.09	-19%
adidas AG ADDYY	$97.66	$62.93	-36%
ASICS Corporation ASCCY	$25.77	$19.43	-25%
Deckers Outdoor Corporation DECK	$108.96	$96.18	-12%
On Holding ONON	$38.32	$21.64	-44%
Zhejiang China Commodities City Group 600415	¥10.63	¥18.58	+75%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0551 (0551) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$4.04 versus a price of HK$12.25 — about −67% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 0551?

Our model-based fair value for 0551 is HK$4.04 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$12.25.

What is the quality score of 0551?

0551 has a Quality Score of 58/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0551 (0551)?

0551 reported trailing-twelve-month revenue of about HK$8.0B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 0551?

The net profit margin of 0551 is about 4.3%, meaning it keeps roughly 4.3% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.